Last week, IDL Diagnostics participated in Urology Week 2026 in Växjö. The event brought together professionals from across the field of urology and offered a valuable opportunity to engage in discussions about current research, clinical perspectives and ongoing...
Held from 7-11 September in conjunction with the visit of HRH Crown Princess Victoria of Sweden to Indonesia, Sweden-Indonesia Sustainable Partnership (SISP) Indonesia 2026 brought together more than 50 Swedish companies and Team Sweden organisations to strengthen...
Last Monday, IDL Diagnostics had the honor of attending the diplomatic reception hosted by the Embassy of the Republic of Indonesia to commemorate 81 years of Indonesia's Independence and 76 years of Indonesia–Sweden diplomatic relations. The afternoon brought...
CEO Gustav Sten and CFO Ellen Dittberner present the company’s Q2’26 results – August 20, 2026
We had the pleasure of welcoming our long-term partner Beckman Coulter Diagnostics this week for valuable discussions on the continued sales and market development for our IRMA and ELISA portfolio. Their strong market presence and ability to effectively navigate a...
In the beginning of May, IDL Diagnostics team visited our distributors in Indonesia and the Philippines as part of our ongoing efforts to strengthen local partnerships and stay closely connected to our markets. During our time in Jakarta, we had an in-depth discussion...
In the interview, Gustav Sten talks about his new role, his journey within the company, and reflects on the development under Anders Hultman’s leadership. He also shares his priorities going forward, with a focus on commercialization and continued growth.
IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following the Annual General Meeting, succeeding Anders Hultman. Gustav Sten...
CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q1’26 results – May 13, 2026 Q1 Interview: Redeye talks with CEO Anders Hultman
On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here
